Michael J. Bourque - 27 Feb 2026 Form 4 Insider Report for Inogen Inc (INGN)

Signature
/s/ Mary Wright, as Attorney-in-Fact
Issuer symbol
INGN
Transactions as of
27 Feb 2026
Net transactions value
-$155,135
Form type
4
Filing time
03 Mar 2026, 16:57:16 UTC
Previous filing
03 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bourque Michael J. EVP, CFO & Treasurer C/O INOGEN, INC., 500 CUMMINGS CENTER, SUITE 2800, BEVERLY /s/ Mary Wright, as Attorney-in-Fact 03 Mar 2026 0001638420

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Award $5,331 +874 +1.8% $6.10 50,020 01 Mar 2026 Direct F1
transaction INGN Common Stock Options Exercise $0 +25,000 +50% $0.000000 75,020 01 Mar 2026 Direct
transaction INGN Common Stock Tax liability $56,962 -9,338 -12% $6.10 65,682 01 Mar 2026 Direct F2
transaction INGN Common Stock Award $0 +28,875 +44% $0.000000 94,557 01 Mar 2026 Direct F3
transaction INGN Common Stock Tax liability $64,752 -10,615 -11% $6.10 83,942 01 Mar 2026 Direct F4
transaction INGN Common Stock Options Exercise $0 +17,007 +20% $0.000000 100,949 01 Mar 2026 Direct
transaction INGN Common Stock Tax liability $38,753 -6,353 -6.3% $6.10 94,596 01 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Award $0 +39,000 $0.000000 39,000 27 Feb 2026 Common Stock 39,000 Direct F5, F6
transaction INGN Restricted Stock Unit Options Exercise $0 -25,000 -50% $0.000000 25,000 01 Mar 2026 Common Stock 25,000 Direct F5, F7
transaction INGN Restricted Stock Unit Options Exercise $0 -17,007 -33% $0.000000 34,013 01 Mar 2026 Common Stock 17,007 Direct F5, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
F2 The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
F3 The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024.
F4 The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026.
F5 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F6 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
F7 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
F8 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.